ArticleClinical hematology international2024

Human herpesvirus type 6 reactivation after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide and antithymocyte globulin: risk factors and clinical impact.

Annalisa Paviglianiti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.